Strategy for eliminating gastric cancer in Japan (Q34300591)

1 August 2017

Strategy for eliminating gastric cancer in Japan (English)

1 reference

1 August 2017

1 reference

3

David Y Graham

1 reference

1 August 2017

Masahiro Asaka

1

1 reference

PubMed ID

21073603

1 August 2017

Mototsugu Kato

series ordinal

2

1 reference

1 August 2017

1 December 2010

1 reference

1 August 2017

1 reference

1 August 2017

15

1 reference

1 August 2017

486-490

1 reference

1 August 2017

6

1 reference

Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188349

Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188349

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188349

The Japanese guidelines for gastric cancer screening

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188349

Helicobacter pylori infection and gastric cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188349

[Extermination of gastric cancer from Japan].

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188349

Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188349

The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188349

Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188349

Correlation of serum pepsinogens and gross appearances combined with histology in early gastric cancer

28 October 2018

1 reference

12 December 2020

Prevention of gastric cancer by Helicobacter pylori eradication

1 reference

12 December 2020

Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study

1 reference

12 December 2020

Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer

1 reference

12 December 2020

The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan: a population-based case-control study

1 reference

12 December 2020

Serum pepsinogen in screening for gastric cancer

1 reference

12 December 2020

The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer

1 reference

12 December 2020

10.1111/J.1523-5378.2010.00799.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

PubMed ID

21073603